Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
Clinical trial NCT02338999 · COMPLETED
Trial details
- NCT number
- NCT02338999
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-18
- Primary completion
- 2020-07-14
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.